BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Beckman Laser Institute - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Beckman Laser Institute
X-ORIGINAL-URL:https://leadersinlight.com
X-WR-CALDESC:Events for Beckman Laser Institute
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260514T120000
DTEND;TZID=America/Los_Angeles:20260514T130000
DTSTAMP:20260513T140603
CREATED:20260513T182215Z
LAST-MODIFIED:20260513T182215Z
UID:34294-1778760000-1778763600@leadersinlight.com
SUMMARY:James G. Fujimoto\, PhD
DESCRIPTION:Optical Coherence Tomography: History\, Evolution and Future Prospects\nAbstract  \nOptical coherence tomography (OCT) is an example of a biomedical technology that has been translated from research to clinical practice. OCT performs “optical biopsy”\, visualizing pathology in situ and in real time without excision or processing. The development of OCT would not have been possible without a complex ecosystem involving physics\, engineering\, and clinical medicine; government funding of fundamental and clinical research; collaborative and competitive research in the academic sector; entrepreneurship and industry; and economic and societal impact. OCT has become a standard of care in ophthalmology with millions of imaging procedures every year. It can detect eye disease at early treatable stages before vision impairment occurs\, monitor disease progression and assess treatment response. The development of OCT angiography (OCTA) enabled depth resolved visualization of microvasculature using motion contrast from flowing blood. Technologies such as high speed\, swept source OCT (SS-OCT) can image at 1050 nm wavelengths with improved image penetration\, enabling advanced OCTA protocols which can assess blood flow speed at the capillary level. Advances in high resolution spectral domain (SD-OCT) enable imaging of new biomarkers in the outer retina and RPE-Bruchs membrane complex. OCT has had a powerful impact on health and wellbeing while also reducing health care costs. Continued research and development by the international community has made major advances in performance and functionality\, enabling exciting new applications in diverse areas. This presentation discusses the development of OCT\, its translation to clinical practice and its future potential. \nBiography \nJames Fujimoto is Elihu Thomson Professor of Electrical Engineering at MIT\, visiting professor of ophthalmology at Tufts University School of Medicine\, and adjunct professor at the Medical University of Vienna. His group and collaborators were responsible for the invention and development of OCT\, performing some of the first studies in ophthalmology. Working with Carmen Puliafito and Eric Swanson\, he cofounded the startup company Advanced Ophthalmic Devices\, which developed ophthalmic OCT and was acquired by Carl Zeiss. He also cofounded\, with Eric Swanson and Mark Brezinski\, LightLab Imaging\, which developed intravascular OCT and was acquired by Goodman\, Ltd. and St. Jude Medical. Dr. Fujimoto received the Zeiss Research Award in 2011\, Optical Society of America Ives Medal in 2015\, Beckman-Argyros Award in Vision Research in 2017 and the Honda Prize in 2024. He was co-recipient of the Champalimaud Vision Prize in 2012\, National Academy of Engineering Fritz J. and Dolores H. Russ Award in 2017\, European Inventor Award in 2017\, Lasker-DeBakey Clinical Medical Research Award in 2023 and National Medal of Technology and Innovation in 2023. Dr. Fujimoto has honorary doctorates from the Nicolaus Copernicus University in Poland and Friedrich Alexander University of Erlangen-Nuremberg and is a member of the National Academy of Engineering\, National Academy of Sciences\, and American Academy of Arts and Sciences. \n  \nREGISTER HERE FOR ZOOM \n  \nClick here to register for in-person attendance (lunch will be served) \n 
URL:https://leadersinlight.com/event/james-fujimoto-phd/
LOCATION:BLI Library
CATEGORIES:2025 Hybrid Seminar Series,LAMP Seminar
ATTACH;FMTTYPE=image/jpeg:https://leadersinlight.com/wp-content/uploads/2026/05/J-Fujimoto_192.jpg
END:VEVENT
END:VCALENDAR